Laila Pharmaceuticals PVT. LTD.
Records under this name other than patents Laila Pharmaceuticals PVT. LTD. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Laila Pharmaceuticals PVT. LTD.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,022,416 | Novel Highly Bioavailable, Water Soluble and Sustained Release Nanoformulations Hydrophobic Plant Derived Compounds and Extracts Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |
| US 8,632,815 | Process for nanoemulsification of curcumin and derivatives of curcumin Lapsed on the fee record Ended Jan 21, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 21, 2026 | USPTO record |
| US 8,759,403 | Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions Lapsed on the fee record Ended Jun 24, 2022 · USPTO record | Lapsed on the fee record | Ended Jun 24, 2022 | USPTO record |
| US 8,680,143 | Orally active curcuminoid compounds Lapsed on the fee record Ended Mar 25, 2022 · USPTO record | Lapsed on the fee record | Ended Mar 25, 2022 | USPTO record |
| US 8,535,693 | Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof Lapsed on the fee record Ended Sep 17, 2017 · USPTO record | Lapsed on the fee record | Ended Sep 17, 2017 | USPTO record |